The international law firm Milbank LLP advised Joh. Berenberg, Gossler & Co. KG as super senior lender on the financing of Biotest AG. The new financing comprises a term loan and a revolving credit line with a volume of more than €200 million.

Headquartered in Dreieich, Hesse, Biotest is a provider of plasma proteins and biotherapeutic drugs with more than 1,700 employees. The company specializes in clinical immunology, hematology, intensive care and emergency medicine. Biotest develops and distributes immunoglobulins, coagulation factors and albumin, which are produced based on human blood plasma and are used for the treatment of diseases of the immune system or hematopoietic systems. The ordinary and preference shares of Biotest AG are listed in the Prime Standard of the German Stock Exchange.

Berenberg was founded in 1590 and is today one of Europe's leading private banks with its Wealth and Asset Management, Investment Banking and Corporate Banking divisions. The Hamburg-based bank is managed by general partners and has a strong presence in the financial centers of Frankfurt, London and New York.

A Milbank team led by partner Thomas Ingenhoven comprehensively advised the Joh. Berenberg, Gossler & Co. KG on the financing.

Advisor to Joh. Berenberg, Gossler & Co. KG: Milbank LLP

Thomas Ingenhoven (lead), Odilo Wallner, Michael Henn (all Finance, Frankfurt).

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.